According to Adagene's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.2121. At the end of 2022 the company had a P/S ratio of 6.19.
Year | P/S ratio | Change |
---|---|---|
2022 | 6.19 | -82.12% |
2021 | 34.6 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Organovo ONVO | 49.1 | 302.24% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 17.4 | 42.52% | ๐ฌ๐ง UK |
Novavax NVAX | 3.06 | -74.95% | ๐บ๐ธ USA |
Novocure
NVCR | 4.54 | -62.84% | Jersey |